Abstract
? Phenotypic driver mutations in JAK2, calreticulin, and MPL are present in 85% to 90% of myeloproliferative neoplasms and induce constitutive activat......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
